MedAvail Holdings, Inc , a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada.
infoMedAvail is a small cap stock with a total market cap of 961.06M.
infoThey trade on the NASDAQ and had their IPO 13 years and 3 months ago.
infoMedAvail currently employs 279 people.
infoAs of Friday, Aug 11 2023, MedAvail’s share price is $11.91.
News Relating to MedAvail
Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q1 2023 Earnings Call Transcript
Thursday May 18 2023 at 22:46
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2023 Results Conference Call May 18, 2023 4:30 PM ET Company Participants Steve Halper – Managing Director at LifeSci Advisors Mark Doerr – Chief Executive Officer Ramona Seabaugh – Chief Financial Officer Conference Call Participants Lucas Romanski – TD Cowen Operator Hello, everyone. And thank you for joining MedAvail’s 2023 First Quarter Conference Call.
GlobeNewsWire
MedAvail to Report First Quarter 2023 Financial Results on May 18
Thursday May 18 2023 at 07:00
Management to host investor conference call and webcast at 4:30pm EDT today Management to host investor conference call and webcast at 4:30pm EDT today
GlobeNewsWire
MedAvail to Report First Quarter 2023 Financial Results on May 15
Monday May 15 2023 at 12:21
Management to host investor conference call and webcast at 4:30 pm EDT today Management to host investor conference call and webcast at 4:30 pm EDT today
Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q4 2022 Earnings Call Transcript
Friday Apr 14 2023 at 15:24
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q4 2022 Earnings Conference Call April 13, 2023 4:30 PM ET Company Participants Steven Halper – MD, LifeSci Advisors, IR Mark Doerr – CEO Ramona Seabaugh – CFO Conference Call Participants Charles Rhyee – Cowen & Co. Operator Hello, everyone, and thank you for joining the MedAvail’s 2022 Fourth Quarter and Full Year Conference Call. My name is Doug.
GlobeNewsWire
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
Wednesday Apr 12 2023 at 16:05
Management to host investor conference call and webcast at 4:30pm EDT on that day Management to host investor conference call and webcast at 4:30pm EDT on that day
GlobeNewsWire
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Thursday Mar 16 2023 at 16:05
Management to host investor conference call and webcast at 4:30pm ET on that day Management to host investor conference call and webcast at 4:30pm ET on that day
Benzinga
Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More – Herbalife Nutrition (NYSE:HLF), AppHarvest (NASDAQ:APPH)
Monday Dec 12 2022 at 08:36
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Here’s the latest list of major oversold players in this sector.
Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q3 2022 Earnings Call Transcript
Sunday Nov 13 2022 at 19:40
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Ji-Yon Yi – IR Mark Doerr – CEO Ramona Seabaugh – CFO Conference Call Participants Brooks O’Neil – Lake Street Capital Markets Operator Hello, everyone, and thank you for joining the MedAvail’s 2022 Third Quarter Earnings Conference Call. My name is Daren, I’ll be your operator for today.
Business Wire
MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
Thursday Oct 27 2022 at 16:05
MISSISSAUGA, Ontario & PHOENIX, Ariz.
Business Wire
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Tuesday Aug 30 2022 at 16:05
MISSISSAUGA, Ontario & PHOENIX, Ariz.–(BUSINESS WIRE)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail’s management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest
Business Wire
MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
Wednesday Aug 17 2022 at 16:05
MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 1:20 p.m. ET. Interested parties can access a live webcast of the presentation directly by following this link. An archived w
Seeking Alpha
MedAvail Holdings, Inc.’s (MDVL) CEO Mark Doerr on Q2 2022 Results – Earnings Call Transcript
Thursday Aug 11 2022 at 20:51
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Caroline Paul – Investor Relations Mark Doerr – Chief Executive Officer Ramona Seabaugh – Chief Financial Officer Conference Call Participants Charles Rhyee – Cowen Brooks O’Neil – Lake Street Capital Markets Operator Good afternoon, and thank you for attending today’s MedAvail Second Quarter 2022 Earnings Call. My name is Austin, and I will be your operator for today.
PennyStocks
5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
Friday Jun 17 2022 at 11:03
Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Business Wire
MedAvail to Participate in Upcoming Investor Conferences
Tuesday Jun 07 2022 at 16:05
MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–(Nasdaq: MDVL)— MedAvail Holdings, Inc. (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will be participating in the following virtual investor conferences. Lytham Partners Summer 2022 Investor Conference Tuesday, June 21, 2022 to Wednesday, June 22, 2022 Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern Time Cowen 7th Annual FutureHealth Conference Fireside chat on Wednesday, Jun
Zacks Investment Research
Is MedAvail (MDVL) Outperforming Other Medical Stocks This Year?
Friday May 20 2022 at 11:17
Here is how MedAvail Holdings, Inc. (MDVL) and Mirum Pharmaceuticals, Inc. (MIRM) have performed compared to their sector so far this year.
Benzinga
5 Short Squeeze Candidates To Watch This Week: Vertex Energy Tops List, Medavail Holdings And Camping World Remain Elevated
Monday May 16 2022 at 11:38
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Seeking Alpha
MedAvail Holdings’ (MDVL) CEO Mark Doerr on Q1 2022 Results – Earnings Call Transcript
Thursday May 12 2022 at 22:29
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Caroline Paul – Investor Relations Mark Doerr – Chief Executive Officer Ramona Seabaugh – Chief Financial Officer Conference Call Participants Charles Rhyee – Cowen Operator Hello, and a warm welcome to the MedAvail 2022 First Quarter Earnings Conference Call. My name is Lisa, and I will be your operator today.
PennyStocks
3 Short Squeeze Penny Stocks To Buy For Under $5 This Week
Monday May 09 2022 at 12:39
Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace
Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop
Monday May 09 2022 at 12:18
Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel’s top short squeeze candidates.
PennyStocks
Hot Penny Stocks to Buy Right Now? 3 That Are Climbing Today
Thursday Apr 21 2022 at 15:30
Check these 3 penny stocks out that are climbing right now The post Hot Penny Stocks to Buy Right Now? 3 That Are Climbing Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks
Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April
Tuesday Apr 19 2022 at 17:08
Check these three penny stocks out for your watchlist right now The post Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Zacks Investment Research
MedAvail Holdings, Inc. (MDVL) Moves to Buy: Rationale Behind the Upgrade
Friday Apr 08 2022 at 13:32
MedAvail Holdings, Inc. (MDVL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
PennyStocks
Trading Penny Stocks on April 8th? What to Know on Friday
Friday Apr 08 2022 at 09:31
Here’s what you need to know about trading penny stocks on April 8th The post Trading Penny Stocks on April 8th? What to Know on Friday appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Benzinga
Executives Buy Over $1.5M Of 4 Penny Stocks
Thursday Apr 07 2022 at 14:36
US crude oil futures traded lower on Thursday. Investors, meanwhile, focused on some notable insider trades.
PennyStocks
Trading Penny Stocks on April 7th? Fed News Causes Market Movement
Thursday Apr 07 2022 at 09:29
Here’s what you need to know about trading penny stocks on April 7th The post Trading Penny Stocks on April 7th? Fed News Causes Market Movement appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Seeking Alpha
MedAvail Holdings, Inc. (MDVL) CEO Mark Doerr on Q4 2021 Results – Earnings Call Transcript
Thursday Mar 24 2022 at 20:41
MedAvail Holdings, Inc. (MDVL) CEO Mark Doerr on Q4 2021 Results – Earnings Call Transcript
Seeking Alpha
MedAvail Holdings (MDVL) CEO Ed Kilroy on Q3 2021 Results – Earnings Call Transcript
Monday Nov 08 2021 at 20:25
MedAvail Holdings (MDVL) CEO Ed Kilroy on Q3 2021 Results – Earnings Call Transcript
Benzinga
Why MedAvail Holdings Shares Are Trading Higher Today
Thursday Sep 16 2021 at 15:29
MedAvail Holdings (NASDAQ:MDVL) shares are trading higher after the company announced it signed an agreement with IMA Medical Group to open four SpotRx locations in Florida. MedAvail’s stock is trading up 9.48% to a price of $3.58.
InvestorPlace
The Revenue Numbers for SOS Limited Literally Don’t Add Up
Wednesday Sep 15 2021 at 16:32
Where are the profits it claims? SOS stock is not worth more than $1.14, given that reported commodity profits aren’t on the balance sheet.
Business Wire
IMA Medical Group Signs Agreement with MedAvail to Open Four SpotRx Locations in Florida
Wednesday Sep 15 2021 at 16:05
MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, expects to open an initial four SpotRx locations in 2021 with IMA Medical Group in Florida. In-clinic SpotRx kiosks and courier home delivery will be available to patients at four IMA Medical clinic locations in central Florida. SpotRx Pharmacy is the retail pharmacy brand owned and operated by MedAvail in the United States, which deploys and operat
MedAvail Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
MedAvail’s Altman Z-score is 6.52 which is in the safe zone. This indicates the company is financially stable and less likely to experience financial distress or bankruptcy.
Derived from SEC.GOV filing dataopen_in_new
MedAvail Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, there has been no insider trading in MedAvail.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
MedAvail’s Income Quality of 0.76 is greater than its Industry Group of 0.13 (484.6% greater)
MedAvail’s Income Quality of 0.76 is greater than its Major Industry Group of 0.59 (28.8% greater)
MedAvail’s Income Quality of 0.76 is lower than its Sector of 0.87 (-12.6% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
MedAvail’s Current Ratio of 6.34 is greater than its Industry Group of 1.2 (428.3% greater)
MedAvail’s Current Ratio of 6.34 is greater than its Major Industry Group of 1.59 (298.7% greater)
MedAvail’s Current Ratio of 6.34 is greater than its Sector of 1.39 (356.1% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-18.34 & -5.59)
Cannot compare a negative PE Ratio (-18.34 & -0.35)
Cannot compare a negative PE Ratio (-18.34 & 6.37)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
MedAvail’s PB Ratio of 230.53 is greater than its Industry Group of 2.55 (8940.4% greater)
MedAvail’s PB Ratio of 230.53 is greater than its Major Industry Group of 1.42 (16134.5% greater)
MedAvail’s PB Ratio of 230.53 is greater than its Sector of 1.63 (14042.9% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
MedAvail’s ROE of -12.57 is lower than its Industry Group of -0.5 (-2414.0% lower)
Cannot compute a percentage difference when there are zeros in the calculation
MedAvail’s ROE of -12.57 is lower than its Sector of 0.08 (-15812.5% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
MedAvail’s ROCE of -1.26 is lower than its Industry Group of -0.36 (-250.0% lower)
MedAvail’s ROCE of -1.26 is lower than its Major Industry Group of -0.02 (-6200.0% lower)
MedAvail’s ROCE of -1.26 is lower than its Sector of 0.06 (-2200.0% lower)
Derived from SEC.GOV filing dataopen_in_new